Innate and adaptive immune responses in asthma

Area of Science:

• Immunology
• Respiratory Medicine

Background:

• Asthma is recognized as an airway inflammatory disorder driven by T helper type 2 (T(H)2) cells, leading to IgE production and mast cell/eosinophil recruitment.
• Current treatments often involve inhaled corticosteroids targeting T(H)2-mediated inflammation.
• Limited success with solely anti-inflammatory approaches highlights the need to explore other immune pathways in asthma.

Purpose of the Study:

• To explore the role of innate immunity in asthma pathogenesis.
• To identify novel therapeutic targets beyond T(H)2-driven adaptive immunity.
• To leverage recent advances in understanding innate immune responses for disease management.

Main Methods:

• Review of current research on T(H)2 cell-dependent adaptive immunity in asthma.
• Investigation of innate immune pathways, including stimulation by pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs).
• Analysis of dendritic cell (DC) activation and trafficking, innate cytokine sources, and novel T cell subsets and lymphoid cells.

Main Results:

• The limitations of targeting only T(H)2-driven adaptive immunity in asthma treatment are evident.
• The innate immune response plays a crucial sentinel role in asthma.
• New therapeutic targets are emerging from understanding innate immune stimulation and cellular components.

Conclusions:

• Asthma management requires a broader perspective that includes the innate immune system.
• Targeting innate immune pathways offers promising new strategies for asthma prevention and treatment.
• Further research into PAMPs, DAMPs, DCs, and novel immune cells can lead to innovative therapies.